Cardiologists Expected This New Drug To Prevent Heart Attacks — So Why Did It Fail?

WEDNESDAY, Sept. 9, 2026— A drug that heart doctors widely expected to become the next major weapon against heart attacks has failed in a large clinical trial, drugmaker Novartis announced.The experimental drug, pelacarsen, did lower blood levels...